Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2047647 | 0.82 | — | — | |
| SCHEMBL18729170 | 0.80 | — | — | |
| SCHEMBL844611 | 0.80 | — | — | |
| SCHEMBL6070428 | 0.80 | — | — | |
| SCHEMBL17784199 | 0.79 | — | — | |
| SCHEMBL14117987 | 0.79 | TGM2 (0.33) | ALDH1A1MAPTMEN1LMNAPOLB | |
| SCHEMBL18862023 | 0.77 | — | — | |
| SCHEMBL239979 | 0.76 | — | — | |
| SCHEMBL4515091 | 0.76 | — | — | |
| SCHEMBL29352025 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220263028-A1 | CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-08-18 | — | — | US | claimed |
| EP-1919979-B2 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | CREABILIS THERAPEUTICS SPA (IT) | 2017-03-29 | — | — | EP | claimed |
| US-20100292209-A1 | METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE NEUROTROPHIC FACTOR SIGNALING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-11-18 | — | — | US | claimed |
| WO-2008121346-A1 | METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE NEUROTROPHIC FACTOR SIGNALING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-10-09 | — | — | WO | claimed |
| EP-1919979-A1 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | Creabilis Therapeutics S.P.A. (IT) | 2008-05-14 | — | — | EP | claimed |
| WO-2007022999-A1 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | CREABILIS THERAPEUTICS S.P.A. (IT) | 2007-03-01 | — | — | WO | claimed |
| US-20260136750-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| US-20260096342-A1 | HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME AND LIGHT EMITTING DEVICE INCLUDING THE SAME | LT MATERIALS CO LTD (KR) | 2026-04-02 | — | — | US | disclosed |
| US-20260090188-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2026-03-26 | — | — | US | disclosed |
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2026-03-12 | — | — | US | disclosed |
| EP-4707356-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| US-20260026190-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LT MATERIALS CO LTD (KR) | 2026-01-22 | — | — | US | disclosed |
| EP-4682150-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LT Materials Co., Ltd. (KR) | 2026-01-21 | — | — | EP | disclosed |
| JP-2001346574-A | MONOLAYER SHEET STRUCTURE OF PRIMARY STEM CELL AND METHOD FOR FORMING THE SAME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL & TECHNOLOGY | 2001-12-18 | — | — | JP | disclosed |
| EP-1091962-A1 | INDOLOCARBAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND CANCER | Bayer Aktiengesellschaft (DE) | 2001-04-18 | — | — | EP | disclosed |
| EP-0971717-A4 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | BRISTOL MYERS SQUIBB CO (US) | 2000-04-12 | — | — | EP | disclosed |
| EP-0971717-A1 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | Bristol-Myers Squibb Company (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-2000001699-A1 | NOVEL INDOLOCARBAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-13 | — | — | WO | disclosed |
| US-6013646-A | ALZHEIMER'S DISEASE | BAYER CORPORATION (US) | 2000-01-11 | — | — | US | disclosed |
| WO-1998007433-A1 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026190-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LBR, CBR1, CRY1 | ALDH1A1 892/4885MAPT 4314/4885MEN1 2433/4885 |
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYC1, CRY2 | ALDH1A1 1138/4885MAPT 3892/4885MEN1 319/4885 |
| US-20260136750-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | CCNL2, CRY1, CRY2 | ALDH1A1 507/4885MAPT 3705/4885MEN1 633/4885 |
| US-20260090188-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, SCO2 | ALDH1A1 629/4885MAPT 3663/4885MEN1 1141/4885 |
| US-20260096342-A1 | HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME AND LIGHT EMITTING DEVICE INCLUDING THE SAME | CBR1, HCRTR2, GLRA1 | ALDH1A1 1021/4885MAPT 3736/4885MEN1 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.